Stock comparison
BlackRock Technology and Private Equity Term
Eli Lilly
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
BTX
BlackRock Technology and Private Equity Term
Market cap
$1.04B
Sector
Healthcare
LLY
Eli Lilly
Market cap
$1T
Sector
Healthcare
Overall winner
Eli Lilly LLY
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | BTX | LLY | Winner |
|---|---|---|---|
| Warren Buffett | 44D | 72B | LLY |
| Benjamin Graham | 46D | 86A | LLY |
| Philip Fisher | 62C | 86A | LLY |
| Peter Lynch | 56C | 74B | LLY |
| Joel Greenblatt | 44D | 78C | LLY |
| Charlie Munger | 41D | 85A | LLY |
| Terry Smith | 45D | 77C | LLY |
Side-by-side metrics
| Metric | BTX | LLY |
|---|---|---|
| Market cap | $1.04B | $1T |
| P/E (TTM) | 50.0x | 36.6x |
| EV/EBIT | 27.0x | 34.1x |
| ROIC (TTM) | 3.85% | 32.06% |
| Gross margin | 100.0% | 83.51% |
| Net margin | 87.75% | 34.98% |
| Revenue CAGR 5y | - | 23.17% |
| EPS CAGR 5y | - | 40.81% |
| Debt / Equity | - | 1.4x |
| Dividend yield | 9.29% | 0.62% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
BTX leads on
- Debt / Equity-vs 1.4x+100%
- Dividend yield9.29%vs 0.62%+93%
- Net margin87.75%vs 34.98%+60%
- EV/EBIT27.0xvs 34.1x+21%
LLY leads on
- Market cap$1Tvs $1.04B+100%
- ROIC (TTM)32.06%vs 3.85%+88%
- P/E (TTM)36.6xvs 50.0x+27%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.